T
The Naughty Needle
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | A | 2 | 8.6 | 7.4 | 9.8 | 12 Dec 2025 |
| 5-amino-1MQ | X | 1 | 7.2 | 7.2 | 7.2 | 27 Feb 2025 |
| AICAR | X | 1 | 8.3 | 8.3 | 8.3 | 21 May 2025 |
| Alprostadil | X | 1 | 6.3 | 6.3 | 6.3 | 13 Feb 2025 |
| Anavar (Oxandrolone) Raw | X | 1 | 9.5 | 9.5 | 9.5 | 24 Apr 2025 |
| ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | X | 1 | 8.1 | 8.1 | 8.1 | 3 Jul 2025 |
| Botulinum toxin | X | 1 | 10.0 | 10.0 | 10.0 | 13 Feb 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X | 1 | 8.0 | 8.0 | 8.0 | 11 Jun 2025 |
| Cartalax | X | 1 | 8.0 | 8.0 | 8.0 | 13 Feb 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X | 1 | 9.3 | 9.3 | 9.3 | 27 Feb 2025 |
| Cortagen | X | 1 | 9.7 | 9.7 | 9.7 | 7 May 2025 |
| Drostanolone Propionate (Mast P) Raw | X | 1 | 6.8 | 6.8 | 6.8 | 24 Apr 2025 |
| Dutasteride | X | 1 | 10.0 | 10.0 | 10.0 | 25 Apr 2025 |
| Enclomiphene | X | 1 | 6.5 | 6.5 | 6.5 | 21 May 2025 |
| GHRP-2 Acetate | X | 1 | 5.6 | 5.6 | 5.6 | 3 Jul 2025 |
| GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | X | 1 | 6.9 | 6.9 | 6.9 | 14 Jan 2025 |
| Hexarelin | X | 1 | 8.3 | 8.3 | 8.3 | 8 Jul 2025 |
| HGH 191AA (Somatropin) | X | 1 | 7.7 | 7.7 | 7.7 | 13 Jun 2025 |
| HGH Fragment 176-191 | X | 1 | 7.9 | 7.9 | 7.9 | 3 Jun 2025 |
| Hyaluronic acid | X | 1 | 10.0 | 10.0 | 10.0 | 28 Mar 2025 |
| IGF-1 LR3 | X | 1 | 9.3 | 9.3 | 9.3 | 27 Feb 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X | 1 | 6.7 | 6.7 | 6.7 | 27 Feb 2025 |
| L-Carnitine 500mg | X | 1 | 10.0 | 10.0 | 10.0 | 11 Jun 2025 |
| Letrozole | X | 1 | 10.0 | 10.0 | 10.0 | 17 Dec 2024 |
| LGD-4033 (Ligandrol) Raw | X | 1 | 7.1 | 7.1 | 7.1 | 13 Jun 2025 |
| Lipo-B 216mg | X | 1 | 10.0 | 10.0 | 10.0 | 25 Apr 2025 |
| Minoxidil Oral | X | 1 | 6.7 | 6.7 | 6.7 | 27 Feb 2025 |
| MT-1 | X | 1 | 9.3 | 9.3 | 9.3 | 14 Jan 2025 |
| NA Selank Amidate | X | 1 | 5.1 | 5.1 | 5.1 | 3 Jun 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X | 1 | 7.0 | 7.0 | 7.0 | 11 Jun 2025 |
| Pinealon | X | 1 | 10.0 | 10.0 | 10.0 | 13 Feb 2025 |
| Primobolan E | X | 1 | 9.1 | 9.1 | 9.1 | 16 Mar 2025 |
| Primobolan Oral (Methenolone Acetate) | X | 1 | 6.6 | 6.6 | 6.6 | 28 Mar 2025 |
| Romosozumab | X | 1 | 9.0 | 9.0 | 9.0 | 27 Feb 2025 |
| SNAP-8 | X | 1 | 7.2 | 7.2 | 7.2 | 6 May 2025 |
| SS-31 | X | 1 | 7.4 | 7.4 | 7.4 | 9 Jun 2025 |
| Tamoxifen (Nolvadex) | X | 1 | 9.5 | 9.5 | 9.5 | 14 Jan 2025 |
| Vitamin B12 10mg/ml | X | 1 | 9.1 | 9.1 | 9.1 | 14 Jan 2025 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | 5-amino-1MQ | 6.9 | 30mg | 30.5mg | +1.8% | 98.65% | Lab G |
| 25 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 7.5 | 50mg | 60.2mg | +20.4% | 97.34% | Lab F |
| 24 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.5 | 10mg | 11.9mg | +19.1% | 99.76% | Lab A |
| 24 May 2026 | Cartalax | 6.9 | 20mg | 24.0mg | +20.1% | 95.55% | Lab C |
| 24 May 2026 | Alprostadil | 6.8 | 10mg | 10.1mg | +1.0% | 95.11% | Lab B |
| 24 May 2026 | Anavar (Oxandrolone) Raw | 8.2 | 5g | 5.5g | +10.0% | 98.11% | Lab A |
| 24 May 2026 | Cortagen | 9.7 | 30mg | 26.7mg | -11.1% | 97.02% | Lab F |
| 24 May 2026 | MT-1 | 9.9 | 10mg | 11.9mg | +19.0% | 98.11% | Lab D |
| 24 May 2026 | Primobolan Oral (Methenolone Acetate) | 6.8 | 25mg | 29.4mg | +17.7% | 96.48% | Lab G |
| 24 May 2026 | SNAP-8 | 5.1 | 2mg | 1.8mg | -9.2% | 99.65% | Lab A |
| 23 May 2026 | AICAR | 7.3 | 10mg | 12.3mg | +23.3% | 97.92% | Lab C |
| 23 May 2026 | HGH Fragment 176-191 | 8.2 | 15mg | 17.8mg | +18.4% | 97.76% | Lab E |
| 23 May 2026 | ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | 10.0 | 500g | 613.8g | +22.8% | 99.00% | Lab G |
| 17 May 2026 | LGD-4033 (Ligandrol) Raw | 6.9 | 1g | 1.2g | +17.0% | 99.47% | Lab G |
| 17 May 2026 | Lipo-B 216mg | 10.0 | 250mg/ml | 300.1mg/ml | +20.1% | 95.10% | Lab A |
| 17 May 2026 | Romosozumab | 9.3 | 2mg | 2.1mg | +2.6% | 96.38% | Lab G |
| 17 May 2026 | Vitamin B12 10mg/ml | 10.0 | 300mg/ml | 256.3mg/ml | -14.6% | 95.66% | Lab D |
| 26 Jan 2026 | Botulinum toxin | 8.9 | 15mg | 13.9mg | -7.6% | 96.34% | Lab G |
| 26 Jan 2026 | Drostanolone Propionate (Mast P) Raw | 5.7 | 10g | 8.6g | -13.9% | 96.47% | Lab A |
| 19 Jan 2026 | Hyaluronic acid | 9.3 | 10mg | 9.7mg | -3.1% | 98.12% | Lab E |
| 19 Jan 2026 | IGF-1 LR3 | 10.0 | 15mg | 17.5mg | +17.0% | 95.95% | Lab B |
| 19 Jan 2026 | L-Carnitine 500mg | 10.0 | 300mg/ml | 338.5mg/ml | +12.8% | 95.94% | Lab B |
| 9 Jan 2026 | Enclomiphene | 6.4 | 100mg | 92.2mg | -7.8% | 96.25% | Lab E |
| 9 Jan 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 6.4 | 2mg | 2.1mg | +2.7% | 95.82% | Lab A |
| 7 Jan 2026 | Hexarelin | 9.5 | 20mg | 19.3mg | -3.5% | 96.85% | Lab E |
| 7 Jan 2026 | Tamoxifen (Nolvadex) | 9.2 | 50mg | 42.7mg | -14.7% | 97.28% | Lab C |
| 6 Jan 2026 | Pinealon | 10.0 | 2mg | 1.8mg | -12.0% | 99.08% | Lab D |
| 12 Dec 2025 | Tirzepatide | 9.8 | 60mg | 61.3mg | +2.2% | 99.80% | Lab G |
| 12 Dec 2025 | Tirzepatide | 7.4 | 60mg | 67.6mg | +12.7% | 99.70% | Lab G |
| 12 Dec 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 10.0 | 20mg | 24.7mg | +23.7% | 95.71% | Lab D |
| 23 Nov 2025 | Primobolan E | 10.0 | 100mg/ml | 103.5mg/ml | +3.5% | 97.93% | Lab E |
| 23 Nov 2025 | SS-31 | 8.0 | 20mg | 17.6mg | -11.8% | 96.19% | Lab F |
| 14 Nov 2025 | NA Selank Amidate | 6.7 | 2mg | 1.9mg | -3.5% | 96.02% | Lab B |
| 4 Nov 2025 | Dutasteride | 9.4 | 25mg | 30.7mg | +23.0% | 97.12% | Lab G |
| 17 Oct 2025 | GHRP-2 Acetate | 4.3 | 2mg | 2.1mg | +3.5% | 97.02% | Lab B |
| 17 Oct 2025 | Letrozole | 8.7 | 10mg | 9.4mg | -6.2% | 96.29% | Lab D |
| 9 Oct 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.7 | 5mg | 5.1mg | +2.3% | 95.43% | Lab F |
| 9 Oct 2025 | Minoxidil Oral | 7.0 | 10mg | 9.5mg | -4.5% | 97.83% | Lab A |
| 3 Oct 2025 | HGH 191AA (Somatropin) | 6.6 | 15mg | 16.5mg | +10.0% | 97.78% | Lab F |